Trials / Sponsors / Lumos Pharma
Lumos Pharma
Industry · 6 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency Growth Hormone Deficiency (GHD) | Phase 3 | 2026-09-01 |
| Recruiting | Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency Growth Hormone Deficiency (GHD) | Phase 3 | 2026-04-01 |
| Enrolling By Invitation | A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Growth Hormone Deficiency | Phase 2 | 2023-08-01 |
| Completed | Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213) Growth Hormone Deficiency | Phase 2 | 2022-02-18 |
| Active Not Recruiting | PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212) Growth Hormone Deficiency | Phase 2 | 2021-07-14 |
| Completed | Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial) Growth Hormone Deficiency | Phase 2 | 2020-12-31 |